Homology Medicines announces publication of in vivo gene editing data with nuclease-free technology
The publication demonstrates the company's technology induces efficient and precise in vivo gene editing using homologous recombination, a natural DNA correction pathway. This early academic research translated into a scalable process for genetic medicines development.